Reed's (REED) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
4 Dec, 2025Offering details and pricing
Public offering includes shares of common stock and warrants to purchase common stock, with warrants exercisable for five years from the initial exercise date at a specified exercise price, subject to adjustment for certain corporate actions.
Warrants are initially issued in book-entry form through DTC, with the option for holders to request certificated form.
Exercise of warrants can be made for cash or, if no effective registration statement is available, via a cashless exercise formula based on market price and exercise price.
No fractional shares will be issued upon exercise; any fractional interest will be settled in cash or rounded up.
The company pays all transfer agent and DTC fees for same-day processing and electronic delivery of warrant shares.
Underwriters and syndicate
Alliance Global Partners acts as representative of the underwriters for the offering.
Risk factors and disclosures
Warrants are subject to beneficial ownership limitations, generally capped at 4.99% or 9.99% of outstanding common stock, as elected by the holder.
Adjustments to warrant terms are triggered by stock splits, dividends, rights offerings, distributions, or fundamental transactions such as mergers or asset sales.
In the event of a fundamental transaction, holders may receive alternate consideration or require the company to purchase the warrant at its Black-Scholes value.
The company is not required to net cash settle exercises except as specifically provided.
Latest events from Reed's
- Sequential improvements and new growth initiatives set the stage for margin expansion in 2026.REED
Q4 202525 Mar 2026 - Q2 2024 saw double-digit sales growth, margin gains, and improved but still risky profitability.REED
Q2 20241 Feb 2026 - Net sales and margins dropped, but new funding and restructuring target 2025 recovery.REED
Q3 202414 Jan 2026 - Financial restructuring and product innovation set the stage for strong growth in 2025.REED
The Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Gross margin hit 30% as debt fell and new products and capital set up 2025 growth.REED
Q4 202426 Dec 2025 - IPO offers shares and warrants to fund growth amid ongoing losses and pending NYSE listing.REED
Registration Filing2 Dec 2025 - Registration enables resale of 18.8M shares after major financings and debt conversions.REED
Registration Filing29 Nov 2025 - Registering 5M shares for resale after $5M placement; expanding in health-focused beverages.REED
Registration Filing29 Nov 2025 - 18.8 million shares registered for resale as company targets growth in natural beverages.REED
Registration Filing29 Nov 2025